Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Can Fite Biopharma Ltd (NYSE American:CANF)

1.65
Delayed Data
As of 3:57pm ET
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
2.67
-30.67%
Year-to-Date
No recent news for Can Fite Biopharma Ltd.

Today’s Trading

Previous close1.65
Today’s open1.65
Day’s range1.63 - 1.71
Volume28,497
Average volume (3 months)27,665
Market cap$27.0M
Dividend yield--
Data as of 3:57pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-18.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.99%
P/E ratio--
Price/Sales193.49
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
BPTHBio Path Holdings In...-0.02-5.13%
APVOAptevo Therapeutics ...-0.05-2.12%
CRMDCorMedix Inc-0.03-4.35%
ICCCImmuCell Corp-0.02-0.26%
Data as of 7:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 24, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$170.4K
Annual profit (last year)-$6.9M
Net profit margin-4,069.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Pnina Fishman
Chief Operating &
Financial Officer
Motti Farbstein
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts